Rocket Pharmaceuticals (RCKT) EBITDA (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted EBITDA of -$45.36 million for Q2 2026, compared with -$69.11 million a year earlier.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) EBITDA (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Rocket Pharmaceuticals was -$184.09 million; for FY2025, it came in at -$222.88 million.
- In prior years, Rocket Pharmaceuticals' EBITDA was -$265.98 million in FY2024, -$254.72 million in FY2023, -$220.41 million in FY2022 and -$164.01 million in FY2021.
- Quarterly EBITDA has run from a low of -$71.88 million in Q2 2024 to a high of -$41.76 million in Q1 2022 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$46.9 million (Q1 2026), -$42.29 million (Q4 2025) and -$49.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - | -45.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.36 Mn |
| Mar 31, 2026 | -46.90 Mn |
| Dec 31, 2025 | -42.29 Mn |
| Sep 30, 2025 | -49.55 Mn |
| Jun 30, 2025 | -69.11 Mn |
| Mar 31, 2025 | -61.94 Mn |
| Dec 31, 2024 | -60.87 Mn |
| Sep 30, 2024 | -67.57 Mn |
| Jun 30, 2024 | -71.88 Mn |
| Mar 31, 2024 | -65.66 Mn |
| Dec 31, 2023 | -61.88 Mn |
| Sep 30, 2023 | -64.21 Mn |
| Jun 30, 2023 | -67.57 Mn |
| Mar 31, 2023 | -61.06 Mn |
| Dec 31, 2022 | -71.18 Mn |
| Sep 30, 2022 | -57.39 Mn |
| Jun 30, 2022 | -53.21 Mn |
| Mar 31, 2022 | -41.76 Mn |
| Dec 31, 2021 | -43.29 Mn |
| Sep 30, 2021 | -48.85 Mn |
API Access
Rocket Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();